| Literature DB >> 35110267 |
Miguel Guia1, Nilgun Alpay2, António Gerardo1, Yasmin Madney3, Mohamed Abdelrahim3, Haitham Saeed3, Hadeer Harb3, Gil Gonçalves4, Bruno Cabrita5, Jaber Alqahtani6, Mohamad El-Khatib7, Manuel Gómez-Ríos8, Atefeh Fakharian9, Laura Ciobanu10, Habib Md Reazaul Karim11, Edoardo Piervincenzi12, Martin Scharffenberg13, Paschalis Steiropoulos14, William LeMaster15, Igor Barjaktarevic15, Jakob Wittenstein13, Montserrat Diaz-Abad16, Andreas Perren17, Antonello Nicolini18, Savino Spadaro19, Giancarlo Garuti20, Angelo Petroianni21, Antonio Esquinas22.
Abstract
High-flow nasal cannula oxygen therapy (HFNCOT) system consists of an air/oxygen supply system capable of delivering up to 100% humidified and heated oxygen at a flow rate of up to 80 L/min. The system includes a blender, active humidifier, single heated tube, and nasal cannula. HFNCOT has many physiological advantages compared with other standard oxygen therapies, such as anatomical dead space washout, more constant fraction of inspired oxygen, positive end-expiratory (PEEP) effect, supplement of adequate humidification and maintenance of muco-ciliary function. HFNCOT is mostly used for hypoxemic acute respiratory failure, although it also has other indications. HFNCOT is a common choice of physicians as its technology makes it more silent and comfortable. Though HFNCOT is used in many clinical settings, there is a lack of publications addressing devices and initial settings. We present a review on HFNCOT, with focus on device and application methodology.Entities:
Year: 2021 PMID: 35110267 PMCID: PMC8975303 DOI: 10.5152/TurkThoracJ.2021.20213
Source DB: PubMed Journal: Turk Thorac J ISSN: 2148-7197